Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
<p>Abstract</p> <p>A response to and comment on <b>The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury</b>, by Haleema Shakur, Ian Roberts, et al.</p>
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-12-01
|
| Series: | Trials |
| Online Access: | http://www.trialsjournal.com/content/10/1/110 |
| id |
doaj-dfd9cb8254004c938bee7805743b8fc3 |
|---|---|
| record_format |
Article |
| spelling |
doaj-dfd9cb8254004c938bee7805743b8fc32020-11-25T01:47:51ZengBMCTrials1745-62152009-12-0110111010.1186/1745-6215-10-110Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injurySimmon Vincent F<p>Abstract</p> <p>A response to and comment on <b>The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury</b>, by Haleema Shakur, Ian Roberts, et al.</p> http://www.trialsjournal.com/content/10/1/110 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Simmon Vincent F |
| spellingShingle |
Simmon Vincent F Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury Trials |
| author_facet |
Simmon Vincent F |
| author_sort |
Simmon Vincent F |
| title |
Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury |
| title_short |
Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury |
| title_full |
Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury |
| title_fullStr |
Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury |
| title_full_unstemmed |
Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury |
| title_sort |
response to: the brain trial: a randomised, placebo controlled trial of a bradykinin b2 receptor antagonist (anatibant) in patients with traumatic brain injury |
| publisher |
BMC |
| series |
Trials |
| issn |
1745-6215 |
| publishDate |
2009-12-01 |
| description |
<p>Abstract</p> <p>A response to and comment on <b>The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury</b>, by Haleema Shakur, Ian Roberts, et al.</p> |
| url |
http://www.trialsjournal.com/content/10/1/110 |
| work_keys_str_mv |
AT simmonvincentf responsetothebraintrialarandomisedplacebocontrolledtrialofabradykininb2receptorantagonistanatibantinpatientswithtraumaticbraininjury |
| _version_ |
1725014319917170688 |